Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 31 March, 2010

Curanum Ag

EANS-Adhoc: CURANUM AG / Financial Figures 2009

PR Newswire/euro adhoc/
EANS-Adhoc: CURANUM AG / Financial Figures 2009
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc 
with the aim of a Europe-wide distribution. The issuer is solely responsible for
the content of this announcement.

31.03.2010

Ad hoc announcement


                        CURANUM AG publishes 2009 results

          Occupancy stable in 2009, revenue and EBITDA budgets achieved

CURANUM AG, Munich, announces  its  results  for  the  2009  financial  year  at
today's results press conference and analyst meeting in Frankfurt. The  capacity
utilization of care beds and managed apartments was stable in 2009, albeit at  a
somewhat lower average level than in 2008.

Revenue rose by 1.0% from EUR 257.1 million in  2008  to  EUR 259.5  million 
in
2009, an increase of EUR 2.4 million. We thereby  exceeded  our  revenue  
budget
(EUR 257.0 million to EUR 259.0 million). The increase was due to  revenue  
from
our new Scheffelhof  senior  residence  in  Bad  Dürrheim,  the  senior  
citizen
residence and care facility in Braunschweig,  as  well  as  additional  revenues
from our outpatient service in Coburg, and  from  care  services  for  occupants
suffering dementia.

Rental expenses rose by EUR 0.9 million or 1.65% to EUR 55.5  million  
(previous
year: EUR 54.6 million). This was mainly due to the rental  indexations  of  
the
properties we rent. Staff costs increased  by  EUR 2.7  million  or  2.1%,  
from
EUR 127.8 million in 2008 to EUR 130.5 million in 2009.

As a consequence, earnings before interest, tax, depreciation, amortization  and
rents (EBITDAR) amounted to EUR 83.1 million in 2009  (previous  year:  
EUR 83.9
million), reflecting a decline of EUR 0.8 million  or  0.95%  year-on-year.  
The
EBITDAR margin stood at 32.0% (previous year: 32.6%), which  represents  a  peak
outcome on a European peer group comparison.

EBITDA earnings declined from EUR 29.3 million in 2008 to  EUR 27.6  million 
in
2009, which corresponds to an EBITDA margin of 10.64% in this  reporting  period
(previous year: 11.4%).

Compared with  the  previous  year,  depreciation  and  amortization  rose  only
slightly from EUR 9.5 million in 2008 to EUR 9.8 million in  2009,  
representing
an increase of EUR 0.3 million or  3.16%.  As  a  consequence,  earnings  
before
interest and tax (EBIT) amounted to EUR 17.8 million  (previous  year:  
EUR 19.7
million), reflecting an EBIT margin of 6.86% in 2009 (previous year: 7.66%).

The tax rate increased in 2009. Consequently, income tax and deferred  tax  were
around EUR 0.7 million higher than budgeted. At EUR 5.8 million (previous  
year:
EUR 7.0 million) we failed to achieve our budgeted post-tax earnings of  
EUR 6.5
million - EUR 8.5 million. Earnings per share amounted to EUR 0.18 in  the  
2009
reporting period (previous year: EUR 0.22).

Cash flow from operating activities  rose  slightly  from  EUR 19.8  million  
to
EUR 19.9 million as of the end of 2009, and  the  cash  outflow  from  
investing
activities dropped from EUR 18.7 million to EUR 5.2 million in 2009.  Cash  
flow
from  financing  activities  was  again  characterized  by  the  redemption   of
financial liabilities in an amount of EUR 5.6 million  (previous  year:  
EUR 4.9
million), outgoing payments for finance leasing  of  EUR 7.8  million  
(previous
year: EUR 7.6 million), as well as the dividend payment at the  previous  
year's
level at EUR 3.2 million.

The full results for the 2009 financial year are available  on  our  website  at
www.curanum.de in the Investor Relations area.


Munich, March 31, 2010

The Management Board









|Key figures IFRS as of December 31,    |           |               
|2009                                   |           |               
|                               |       |           |               
|                               |       |           |               
|mil.  EUR                      |2009   |2008 1)    |YOY in %       
|                               |       |           |               
|Sales                          |259.5  |257.1      |0.93           
|Staff costs                    |130.5  |127.8      |2.11           
|EBITDAR                        |83.1   |83.9       |-0.95          
|Rental costs                   |55.5   |54.6       |1.65           
|EBITDA                         |27.6   |29.3       |-5.80          
|in % of Sales                  |10.6%  |11.4%      |               
|Depreciation                   |9.8    |9.5        |3.16           
|EBIT                           |17.8   |19.7       |-9.64          
|in % of Sales                  |6.9%   |7.7%       |               
|Financial results              |-8.9   |-9.5       |-6.32          
|EBT                            |8.9    |10.2       |-12.75         
|Net profit                     |5.8    |7.0        |-17.14         
|EPS (EUR) *)                   |0.18   |0.22       |-18.18         
|                               |       |           |               
|Cashflow                       |19.9   |19.8       |0.51           
|CPS (EUR) *)                   |0.62   |0.61       |1.64           
|                               |       |           |               
|Cash and cash equivalents      |8.9    |10.0       |-11.00         
|Equity capital                 |66.1   |64.1       |3.12           
|in % of balance sheet total    |28.0%  |27.0%      |               
|Balance sheet total            |236.4  |237.7      |-0.55          
|                               |       |           |               
|Employees                      |6,055  |5,953      |1.71           
|Facilities                     |69     |68         |1.47           
|Care places                    |7,805  |7,708      |1.26           
|Assisted living apartements    |1,681  |1,638      |2.63           
|                               |       |           |               
|*) Number of unterlying outstanding    |           |               
|shares in 2009: 32,267,835 shares      |           |               
|*) Number of underlying outstanding    |           |               
|shares in 2008: 32,611,091 shares      |           |               
|1) restated in 2009                    |           |               



Further inquiry note:
Marion Mühlschlegel

Tel.  +49 (0)89 242065-68

Email [email protected]
issuer:   CURANUM AG
          Maximilianstr. 35c
          D-80539 München
phone:    +49 (0)89 242065 60
FAX:      +49 (0) 89 242065 10
mail:     [email protected]
WWW:      http://www.curanum.de
sector:   Healthcare Providers
ISIN:     DE0005240709
indexes:  SDAX, CDAX, Classic All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
          Hamburg, Stuttgart, Düsseldorf, regulated dealing: München 
language: English
        
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication.

                                                                                                                                                                                                       

a d v e r t i s e m e n t